melan
dematiac
fungi
known
black
yeast
caus
signific
reoccur
phaeohyphomycosi
chromoblastomycosi
mycetoma
skin
soft
tissu
anim
human
deposit
melanin
fungal
cell
wall
play
import
role
virul
pathogen
pathogen
aid
elud
host
immun
respons
negat
hydrolyt
enzymat
attack
scaveng
free
radic
liber
phagocyt
cell
oxid
burst
black
yeast
exist
either
yeastlik
state
divis
unicellular
bud
grow
filament
speci
known
caus
diseas
classifi
ascomycet
order
chaetothyrial
major
clinic
relev
speci
fall
within
chaetothyrial
belong
famili
herpotrichiellacea
abil
reproduc
unicellular
growth
found
exclus
genu
exophiala
reason
major
dissemin
black
yeast
infect
caus
exophiala
spp
asid
caus
opportunist
superfici
system
mycos
warm
coldblood
anim
exophiala
spp
consid
ubiquit
fungi
histor
isol
varieti
environment
substrat
soil
sediment
decay
wood
plant
materi
drink
water
conclus
diagnosi
phaeohyphomycosi
caus
exophiala
spp
requir
sever
step
includ
histopatholog
examin
clinic
sampl
cultur
follow
microscop
examin
sequenc
repres
barcod
gene
intern
transcrib
spacer
region
region
nuclear
larg
subunit
rdna
gene
case
report
detail
conclus
diagnosi
phaeohyphomycosi
caus
e
attenuata
occur
hind
paw
domest
short
hair
cat
femalespay
domest
shorthair
cat
present
veterinari
evalu
mass
fistul
tract
plantar
surfac
right
hind
paw
immedi
proxim
metatars
foot
pad
slowli
progress
mass
first
notic
cat
owner
approxim
month
prior
present
tent
diagnosi
chronic
inflamm
made
antibiot
therapi
topic
steroid
initi
inject
cefovecin
topic
hydrocortison
condit
respond
therapi
discontinu
week
later
surgic
biopsi
perform
remov
mass
histopatholog
examin
reveal
incomplet
excis
nodular
pyogranulomat
dermat
pannicul
intralesion
pigment
fungal
hypha
phaeohyphomycosi
itraconazol
oral
suspens
mgkg
daili
start
patient
initi
well
postop
week
later
owner
report
cat
becom
letharg
mass
return
new
skin
mass
develop
drain
primari
mass
swab
submit
cultur
fungal
identif
cat
euthan
week
later
due
progress
lethargi
anorexia
develop
distend
abdomen
cat
medic
histori
prior
develop
phaeohyphomycosi
unremark
regularli
vaccin
felin
leukemia
viru
felv
howev
test
felv
felin
immunodefici
viru
fiv
postmortem
examin
reveal
similar
microscop
featur
recurr
mass
compar
prior
biopsi
fig
addit
two
smaller
cutan
mass
observ
one
locat
anterior
surfac
right
forelimb
proxim
carpu
one
locat
plantar
surfac
left
hind
foot
approxim
cm
proxim
metatars
foot
pad
evid
system
mycosi
howev
periton
pleural
effus
observ
along
subacut
centrilobular
hepat
congest
scatter
hepatocyt
necrosi
acut
moder
pulmonari
congest
edema
mild
multifoc
subendocardi
myocardi
fibrosi
felin
coronaviru
felin
infecti
periton
fip
detect
periton
effus
microscop
section
submit
biopsi
pannicul
show
larg
nodular
aggreg
inflammatori
cell
expand
effac
subcuti
occasion
extend
overli
dermi
inflammatori
cell
predomin
epithelioid
macrophag
variabl
number
neutrophil
small
number
lymphocyt
plasma
cell
occasion
scatter
inflammatori
giant
cell
numer
segment
fungal
hypha
scatter
throughout
inflamm
stain
light
yellowbrown
hematoxylin
eosin
stain
strongli
period
acid
schiff
gomori
methenamin
special
stain
hypha
also
stain
strongli
posit
melanin
pigment
special
stain
fig
hypha
frequent
septat
gener
narrow
wide
occasion
torulos
expans
diamet
infrequ
rightangl
branch
dematiac
fungal
isol
denot
obtain
cutan
mass
excis
right
hind
limb
morpholog
phenotyp
isol
examin
compar
publish
descript
e
attenuata
coloni
slow
grow
olivac
black
velveti
appear
black
revers
bud
cell
present
fig
b
pronounc
older
coloni
conidia
singl
cell
variabl
shape
rang
obovoid
narrowli
ellipsoid
fig
conidiogenesi
annellid
conidia
accumul
slimi
mass
intercalari
fig
conidiogen
cell
conidiophor
consist
termin
later
cell
taper
short
beak
apex
septat
base
fig
torulos
mycelium
also
abund
fig
matur
hypha
conidiophor
conidia
dematiac
rdna
gene
variabl
region
nlsu
rdna
gene
amplifi
gdna
sequenc
sequenc
access
genbank
respect
blastn
rdna
sequenc
search
genbank
return
sequenc
homolog
nucleotid
differ
isol
gene
variou
isol
e
attenuata
dataset
rdna
gene
compil
analyz
infer
rel
evolutionari
histori
isol
repres
exophiala
spp
fig
analysi
involv
sequenc
includ
posit
final
dataset
overal
mean
distanc
calcul
standard
error
isol
form
wellsupport
clade
bootstrap
support
isol
e
attenuata
although
micromorpholog
identif
possibl
exophiala
spp
taxa
recogn
suffici
certainti
use
molecular
method
rdna
gene
proven
reliabl
speci
distinct
micromorpholog
e
attenuata
similar
e
spinifera
two
speci
exophiala
spp
produc
larg
erect
welldifferenti
conidiophor
although
morpholog
similar
two
speci
howev
readili
distinguish
molecular
method
use
rdna
gene
demonstr
fig
infect
caus
e
attenuata
consid
rare
overal
evalu
human
anim
mycos
exophiala
spp
base
molecular
identif
limit
phaeohyphomycos
cutan
subcutan
tissu
system
dissemin
e
attenuata
seldom
report
although
mycos
common
speci
exophiala
e
dermatitidi
e
oligosperma
e
phaeomuriformi
e
xenobiotica
e
lecaniicorni
case
report
repres
first
report
e
attenuata
caus
felin
phaeohyphomycosi
north
america
phaeohyphomycos
cat
predominantli
subcutan
wherea
infect
eye
bone
central
nervou
system
organ
rare
subcutan
infect
observ
cat
mainli
occur
via
skin
trauma
due
punctur
wound
often
caus
wood
presum
infect
cat
case
report
occur
similar
manner
via
implant
pathogen
subcutan
tissu
paw
follow
trauma
although
sever
fungal
speci
caus
phaeohyphomycos
previou
case
report
felin
phaeohyphomycos
caus
exophiala
spp
limit
two
speci
e
jeanselmei
e
spinifera
phylogenet
analysi
perform
exophiala
genu
descript
e
attenuata
taxon
reveal
one
e
spinifera
isol
caus
nasal
phaeohyphomycosi
cat
fact
isol
e
attenuata
isol
conclus
group
togeth
within
e
attenuata
clade
remain
two
incid
phaeohyphomycosi
attribut
e
spinifera
ident
one
isol
subsequ
confirm
sequenc
possibl
second
e
spinifera
isol
may
e
attenuata
base
share
similar
micromorpholog
two
taxa
also
given
diagnosi
earli
case
report
made
base
sole
micromorpholog
prior
descript
e
attenuata
taxon
unfortun
voucher
specimen
persev
isol
therefor
imposs
test
hypothesi
use
molecular
method
addit
case
report
occurr
phaeohyphomycosi
cat
caus
e
attenuata
appear
preval
previous
report
fungal
infect
case
one
might
assum
patient
would
predispos
suscept
infect
result
immunocompromis
state
possibl
caus
predispos
diseas
metabol
factor
case
patient
test
felv
fiv
infect
thu
infect
either
immunosuppress
virus
entir
rule
howev
histori
postmortem
evid
suggest
patient
suffer
felv
fiv
similar
presumpt
predispos
immunodefici
also
made
previou
case
report
felin
phaeohyphomycosi
involv
e
spinifera
yet
case
test
felv
found
neg
previou
report
phaeohyphomycosi
involv
e
jeanselmei
also
predispos
immunocompromis
state
determin
case
report
felin
phaeohyphomycosi
involv
e
attenuata
time
identifi
e
spinfera
predispos
factor
could
found
test
fiv
felv
fip
neg
cumul
evid
suggest
healthi
cat
suscept
infect
caus
exophiala
spp
predispos
immunocompromis
state
assum
although
exophiala
spp
sensit
variou
antifung
drug
test
vitro
outcom
treatment
drug
vivo
often
poor
recommend
effect
treatment
phaeohyphomycosi
requir
knowledg
pathogen
ident
drug
suscept
vari
speci
mani
case
involv
exophiala
phaeohyphomycosi
correl
mic
valu
obtain
vitro
clinic
respons
drug
therapi
often
mislead
discrep
attribut
vivo
realiti
pathogen
expos
diurnal
fluctuat
drug
level
moreov
case
infect
compartment
within
area
subcutan
inflamm
unclear
much
drug
actual
penetr
zone
infect
reach
infect
fungu
relaps
follow
drug
therapi
frequent
report
requir
patient
undergo
repetit
longterm
antimycot
therapi
often
lead
offtarget
toxic
hepatotox
interestingli
itraconazol
therapi
associ
congest
heart
failur
small
subset
human
patient
carri
black
box
warn
administr
patient
ventricular
dysfunct
congest
heart
failur
due
neg
inotrop
activ
sporonox
janssen
pharmaceutica
nv
olen
belgium
possibl
area
fibrosi
cat
heart
subclin
predispos
patient
develop
heart
failur
subsequ
bicavitari
effus
administr
itraconazol
although
confirm
case
european
advisori
board
cat
diseas
recommend
aggress
surgic
excis
local
lesion
prior
drug
treatment
deal
subcutan
phaeohyphomycosi
howev
previou
case
report
involv
surgeri
combin
longterm
ketoconazol
fluconazol
therapi
treatment
e
attenuata
felin
phaeohyphomycosi
treatment
strategi
ultim
ineffect
current
case
report
itraconazol
treatment
follow
surgeri
dosag
rate
mgkg
oral
daili
also
resolv
infect
although
sensit
e
attenuata
itraconazol
vitro
previous
report
